RxDoctor Payments Data

Costa Soteropoulos, MD

Pain Medicine · Fredericksburg, VANPI 1548427461

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 462 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations.

$9,193in general payments, 2019–2025

Across 462 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Collegium Pharmaceutical, Inc.$2K
  • Boston Scientific$1K
  • Medtronic$799
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$421
  • GRT US Holding, Inc.$217
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$9,189100%
  • Education$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,193 in reported general payments places this provider in the 85th percentile of 150 pain medicine providers in Virginia.

See all pain medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$297,997
Medicare patients
362
Services billed
3,546

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate28$20,068
MovantikNaloxegol Oxalate23$8,827
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen117$2,515
Lidocaine23$1,999
Oxycodone Hcl127$1,873
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen69$1,536
Gabapentin134$1,503
Morphine Sulfate ErMorphine Sulfate47$1,306
Fentanyl15$1,106
Pregabalin37$874
Methocarbamol59$766
Diclofenac Sodium36$465
Duloxetine Hcl12$409
Tramadol Hcl46$271
Acetaminophen-CodeineAcetaminophen With Codeine12$218

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$1,738$20,06828 claims
Redhill Biopharma Inc.Movantik$113$8,82723 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 150 pain medicine providers in Virginia.

Other pain medicine in Fredericksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →